DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 078502
NDA 078502 describes ELIPHOS, which is a drug marketed by Cypress Pharm and is included in one NDA. It is available from one supplier. Additional details are available on the ELIPHOS profile page.
The generic ingredient in ELIPHOS is calcium acetate. There are two hundred and seventy-seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
The generic ingredient in ELIPHOS is calcium acetate. There are two hundred and seventy-seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
Summary for 078502
| Tradename: | ELIPHOS |
| Applicant: | Cypress Pharm |
| Ingredient: | calcium acetate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 078502
| Ingredient-type | Calcium Cations, Divalent |
| Physiological Effect | Increased Coagulation Factor Activity |
Suppliers and Packaging for NDA: 078502
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ELIPHOS | calcium acetate | TABLET;ORAL | 078502 | ANDA | Carilion Materials Management | 68151-5204 | N | 68151-5204-0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 667MG | ||||
| Approval Date: | Nov 25, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
